U.S. Pharma Stock News

Earlier this week, Zillow released fresh analysis showing the U.S. housing market splitting into two tracks, with well-priced homes going under contract within seven days and often selling above list, while less competitive listings are staying on the market longer than in recent years. Zillow also reported that mortgage rates in its lender marketplace have eased, with the 30-year fixed rate hovering near 6.05% and shorter-term loans dipping below 6%, potentially reshaping buyer behavior...

S&P Global (SPGI) is reshaping its upstream energy business after agreeing to sell its geoscience and petroleum engineering software portfolio to SLB, while rolling out Titan, an AI powered platform for upstream data and insights. See our latest analysis for S&P Global. The recent 7.5% 1 month share price return comes after a weaker 90 day share price return of 18.4% and a 1 year total shareholder return of an 8.3% decline, suggesting momentum has cooled even as S&P Global pushes deeper into...

Earnings miss and mixed signals from Q1 2026 BankUnited (BKU) is in focus after reporting first quarter 2026 results that fell short of analyst revenue and earnings estimates, while also outlining share repurchases, higher net charge offs, and progress on deposits and credit quality. For the quarter ended March 31, 2026, BankUnited reported net interest income of US$248.99 million and total revenue of US$273.69 million. Net income was US$61.88 million, with basic and diluted earnings per...

Dover (DOV) is back in focus after its first quarter 2026 report, which paired double digit revenue growth with a sharp 24% rise in bookings, and management reaffirmed full year earnings and revenue guidance. See our latest analysis for Dover. Dover shares have reacted strongly to the Q1 2026 beat and reaffirmed guidance, with a 30 day share price return of 8.8% and year to date share price return of 14.8%. The 1 year total shareholder return of 34.5% points to momentum that has been building...

What Suncrete’s Recent Share Performance Tells You Suncrete (RMIX) has drawn attention after a 2.1% daily share decline, alongside gains over the past week, month, and past 3 months, prompting investors to reassess expectations around its ready mix concrete logistics business. See our latest analysis for Suncrete. That 2.1% one day share price pullback comes after a sharp run, with a 30 day share price return of 31.13% and a 1 year total shareholder return of 36.72%. This suggests that...

Why Amcor’s new Malaysia facility matters for shareholders Amcor (AMCR) has opened a healthcare packaging coating facility in Subang Jaya, Selangor, investing more than US$35 million in air knife coated medical paper capacity for sterile medical device packaging in Southeast Asia. See our latest analysis for Amcor. Despite the new Malaysia facility supporting Amcor’s healthcare push, the share price has faced pressure, with a 7.13% 7 day share price return decline and a 12.53% 90 day share...

Recent coverage around Fabrinet (FN) has focused on its pattern of topping earnings estimates and the upcoming earnings release, with investor attention tied to demand in optical communications and AI infrastructure markets. See our latest analysis for Fabrinet. Fabrinet’s recent momentum has been strong, with the share price at US$720.19 and a 30 day share price return of 30.48%, building on a 1 year total shareholder return above 250%. This suggests sentiment around optical and AI...

Polibeli Group's FY 2025 Earnings Snapshot Polibeli Group (NasdaqGM:PLBL) has reported its latest figures with trailing twelve month revenue of about US$26.4 million and a loss of US$5.97 million, translating to a basic EPS of US$0.016, alongside reported revenue growth of 32.6% over the past year. The company has seen revenue move from US$22.8 million in the twelve months to the second half of 2023 to US$26.4 million in the latest trailing period, while basic EPS moved from US$0.013 to...

Attention on Sea (NYSE:SE) is picking up as investors look ahead to the company’s next earnings update, with interest anchored on its broad footprint across e-commerce, digital payments, and financial services in multiple regions. See our latest analysis for Sea. Sea’s recent 1 day share price return of 2.51% and 30 day share price return of 9.31% sit against a weaker backdrop, with a 90 day share price return of 32.15% decline and a 1 year total shareholder return of 33.12% loss suggesting...

If you are wondering whether ICON's current share price reflects its true worth, this breakdown will help you connect the recent moves in the stock with what the underlying valuation signals are saying. ICON recently closed at US$102.17, after a 14.6% decline over the past week, with returns of 0.1% over 30 days, a 45.8% decline year to date, and a 29.5% decline over the past year. These price moves come as investors continue to reassess contract research organizations and related healthcare...

Markets are sending mixed signals right now, from shifting sovereign ratings to choppy bond yields and fragile consumer confidence. In this kind of backdrop, many investors are looking less at headlines and more at who is actually running the companies they own. Founder led businesses often have leaders with significant personal capital on the line and a clear long term vision, which can matter when conditions are uncertain. This article looks at our Top Founder Led Companies screener, which...

Why AppLovin’s governance proposal matters for investors AppLovin (APP) has drawn fresh attention after disclosing a shareholder proposal on vote transparency by share class, even as its AI advertising platform, revenue growth, and free cash flow remain central to the stock story. See our latest analysis for AppLovin. Recent trading has been choppy, with a 1-day share price return of 1.29% decline and a 7-day share price return of 6.06% decline. However, a 30-day share price return of 17.60%...

Bank First Corporation has recently reported first-quarter 2026 results, completed a prior buyback of 209,412 shares for US$23.02 million, announced a new share repurchase program of up to US$60 million through April 20, 2028, and increased its quarterly dividend to US$0.55 per share. Together, the expanded buyback capacity and higher dividend highlight a stronger capital return focus that may influence how investors view Bank First’s long‑term capital allocation priorities. With these...

Advanced Micro Devices (AMD) is back in the spotlight after D.A. Davidson upgraded the stock, pointing to strong CPU demand tied to AI workloads following Intel’s upbeat data-center-focused quarterly results. See our latest analysis for Advanced Micro Devices. Those AI driven headlines have fed directly into AMD’s price action, with a 1 day share price return of 13.91%, a 7 day return of 24.94% and a 30 day return of 70.69%. The 1 year total shareholder return sits at 259.88%, which points to...

Nuvalent announced that the FDA accepted its New Drug Application for zidesamtinib in previously treated ROS1-positive NSCLC, with new ARROS-1 data presented at the April 2026 AACR meeting showing clinically meaningful activity and a consistent safety profile in heavily pre-treated patients. A key insight is zidesamtinib’s targeted design for brain penetrance and activity against hard-to-treat ROS1 resistance mutations, including G2032R, in patients who lack effective ROS1 TKI options. We’ll...

Rithm Property Trust (RPT) opened Q1 2026 with total revenue of US$2.9 million and basic EPS of US$0.43 loss per share, giving investors a fresh look at how the business is tracking after a volatile 2025. Over the past year, revenue has moved from US$18.3 million on a trailing basis in Q4 2025 to US$22.0 million by Q1 2026, while trailing twelve month EPS has shifted from a US$0.36 loss to a US$0.30 loss. With the share price around US$14.43, the latest release puts the spotlight squarely on...

If you are wondering whether Gentex is reasonably priced or offering value at its current share price, the key numbers can give some useful clues before you make any decisions. The stock last closed at US$23.88, with returns of 5.5% over the past week, 9.9% over the past month, 0.8% year to date, 14.1% over the past year, and multi-year returns of an 8.7% decline over three years and a 26.0% decline over five years. Recent share price moves often sit against a backdrop of ongoing product...

In the lead-up to Lear’s May 1, 2026 earnings release, analysts have been expecting year-over-year growth in both revenue and earnings for the March quarter, with forecasting tools pointing to a potential earnings beat. This anticipation, set against mixed signals from major automakers like General Motors, has focused attention on Lear’s ability to execute in a shifting auto landscape. We’ll now explore how expectations for a possible earnings beat, reflected in Lear’s Earnings ESP and...

Recent performance snapshot Synchrony Financial (SYF) has attracted attention after a recent share price move, with the stock showing a return of about 17% over the past month despite modest near term pullbacks. Over the past 3 months, Synchrony Financial has recorded a small negative return. Its 1 year and 3 year total returns, at about 51% and roughly 1.8x respectively, may prompt investors to reassess the current risk reward trade off. See our latest analysis for Synchrony Financial. At...

DaVita (NYSE:DVA) reports that its integrated kidney care platform has reached profitability earlier than planned. The platform is delivering improved patient outcomes, supporting the company’s focus on value based care. This marks a material shift in DaVita’s business mix, with potential implications for how investors view its role in healthcare services. DaVita is best known for its dialysis clinics, but the integrated kidney care platform points to a broader role in managing chronic...

Park National (PRK) opened 2026 with Q1 total revenue of US$156.8 million and net income of US$41.7 million, translating to basic EPS of US$2.40, while trailing twelve month revenue reached US$573.2 million and EPS came in at US$10.94. Over the past year, total revenue has moved from US$515.8 million to US$573.2 million on a trailing basis and EPS has gone from US$9.80 to US$10.94. This sets the stage for investors to focus on how the latest quarter fits into that earnings and revenue...

What Stands Out About Federal Agricultural Mortgage Right Now Federal Agricultural Mortgage (AGM) has drawn attention recently after a strong month, with the stock up about 22%, prompting fresh interest in how its agricultural finance model and valuation profile fit into portfolios. See our latest analysis for Federal Agricultural Mortgage. That recent 22.3% 1 month share price return stands out against a year to date share price return of 1.8% decline and a 1 year total shareholder return of...

Investors may be wondering whether Monolithic Power Systems at around US$1,632 per share is still offering value, or if expectations are already fully priced in. The stock has posted returns of 11.1% over the last 7 days, 54.2% over the last 30 days, 74.3% year to date and 181.7% over the past year, with longer term returns of 261.4% over 3 years and 368.4% over 5 years. These strong price moves have kept Monolithic Power Systems firmly on investors' watchlists, as the market reacts to...

On April 16, 2026, Colgate-Palmolive filed additional proxy materials urging shareholders to vote against proposals to remove DEI from board candidate criteria and to require an independent board chairman at its May 8, 2026 annual meeting. This stance highlights Colgate-Palmolive’s preference to retain flexibility over board composition and leadership structure, aligning governance with its existing corporate priorities. We’ll now examine how this board-governance push, alongside the recent...